A 58-year-old man from rural India presents with haematuria and flank pain. Imaging reveals a 6 cm heterogeneous mass in the kidney. Histopathology shows polygonal cells with clear cytoplasm arranged in nests separated by a delicate vascular network. Which is the most common histological subtype of renal cell carcinoma in this patient?
A. Chromophobe renal cell carcinoma
B. Clear cell renal cell carcinoma
C. Papillary renal cell carcinoma
D. Collecting duct carcinoma
Explanation
Most Common Histological Subtype of RCC
Key Point
Clear cell RCC (ccRCC) accounts for 70–80% of all renal cell carcinomas, making it the most common subtype by a significant margin.
Histopathological Features of Clear Cell RCC
Cytoplasm: Abundant lipid and glycogen → clear appearance on H&E staining
Architecture: Nests and sheets of polygonal cells separated by delicate capillary network
Nuclei: Variable size and irregularity (Fuhrman grading)
Vascularity: Highly vascular with prominent hemangiopericytoma-like pattern
Molecular Basis
VHL gene mutation: Present in ~80% of sporadic ccRCC Robbins 10e Ch 20
Loss of chromosome 3p (where VHL resides)
Results in accumulation of HIF-1α → angiogenesis and tumour growth
Comparative Frequency Table
Table
Subtype
Frequency
Key Feature
Prognosis
Clear cell
70–80%
Clear cytoplasm, VHL mutation
Intermediate
Papillary
10–15%
Papillary architecture, MET mutation
Generally better
Chromophobe
5–10%
"Vegetable cells", binucleate, pale cytoplasm
Best
Collecting duct
<1%
Aggressive, tubulopapillary
Worst
Clinical Pearl
Despite being the most common, clear cell RCC has intermediate prognosis. Chromophobe RCC, though rare, has the best 5-year survival (~90%), while collecting duct carcinoma is highly aggressive.
High-YieldNEET PG
The clear cytoplasm in ccRCC is due to lipid and glycogen content, not fat infiltration. This is a critical distinction in histology exams.
Risk Factors for Clear Cell RCC
Smoking (1.5–2× risk)
Obesity
Hypertension
Chronic kidney disease
Von Hippel–Lindau (VHL) syndrome → nearly 100% lifetime risk